Open Access
Subscription or Fee Access
A Localized Warburg Effect and Prostatic Cancer: A Biochemical Approach
Abstract
ABSTRACT
Prostatic cancer is the third most frequent type of cancer among all cancers and the second most diagnosed and death-related among men, 28 men per 100 000 are affected by this disease varying according to the level of development of the country. Prostatic-fluid-secreting luminal cells normally accumulate zinc up to 200 times the amount found in plasma, Zinc blocks m-aconitase physiologically decreasing respiratory chain (OXPHOS) energy production which increases glycolytic energy source, a physiologic Warburg-like effect no found in other tissues. A Localized Warburg effect was surveyed as a causative of prostatic cancer onset and progression. Sexual behavior accompanied with Luminal cells exhaustion which decreases zinc levels render a local inflammation which along with systemic xenobiotics and pro-inflammatory molecules signals in the basal layer of the prostatic secretory glands render an inflammatory micro-environment which precludes malignancy. Furthermore, Loss of lower abdomen, pelvic floor muscles and penile ligaments strength generate an irregular oxygen supply, initially OXPHOS cells undergo Warburg metabolism this onset is not detected in Positron Emission Tomography-Computed Tomography, then OXPHOS cells signal cancer associated fibroblasts (CAFs) which undergo the so-called Reverse Warburg effect, finally adipocytes also signal OXPHOS cells to undergo Warburg metabolism in the metastatic stage of prostatic cancer progression. Prophylactic measures are suggested: Modification in sexual behavior, regain lower abdomen bio-mechanics, Kegels for men, penile ligaments routine of exercises, the maintenance of a referenced body weight and regular aerobic exercises.
Keywords: inflammation, localized, luminal cells, prostatic cancer, Warburg effect
Cite this Article: Vásquez E.F., Chimoy P.J. A Localized Warburg Effect and Prostatic Cancer: A Biochemical Approach. International Journal of Cell Biology and Cellular Processes. 2019; 5(2): 13–29p.
References
Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. Journal of Cancer Research and Practice, 2017; 4(4): 127–129. Hoare M, Narita M. The Power behind the Throne:
Senescence and the Hallmarks of Cancer. Annual Review of Cancer Biology, 2018; 2: 175–194.
Hanahan D, Weinberg RA. Hallmarcks of Cancer: The Next Generation. Cell, 2011; 144 (5): 646–674.
Fouad YA, Aanei C. Revisiting the Hallmarks of Cancer. American Journal of Cancer Research, 2017; 7(5): 1016–1036.
Blackadar CB. Historical Review of the Causes of Cancer. World Journal of Clinical Oncolgy, (2016); 7(1): 54–86.
Clapp R, Howe G, Lefevre MJ. Environmental and Occupational Causes of Cancer: A Review of Recent Scientific Literature. The Lowell Center for Sustainable Production, University of Massachusetts Lowell, 2005; 3.
Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metabolism, 2016; 23: 27–47.
Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell, (2000); 100: 57–70.
Sacho P, Barneda D, Heeschen C. Hallmarks of Cancer Stem Cell Metablism. British Journal of Cancer, 2016; 114: 1305–1312.
Ruiz-Casado A, Martín-Ruiz A, Pérez LM, Provencio M, Fiuza-Luces Carmen, Lucia A. Exercise and the Hallmarks of Cancer. Trends in Cancer 2017; 173: 1–19.
Moses C, Garcia-Bloj, Harvey AR, Blancafort P. Hallmarks of Cancer: The CRISPR Generation. European Journal of Cancer, 2018; 93: 10–18.
Garg AD, Maes H, van Vliet AR, Agostinis P. Targeting the Hallmarks of Cancer with therapy-induced Endoplasmic Reticulum (ER) stress. Molecular and cellular Oncology, 2015; 2:1.
Visvader JE. Cells of Origin in Cancer. Nature, (2011); 469: 314– 322.
Balkwill FR, Capasso M, Hagemann
T. The Tumor Microenvironment at a Glance. Journal of Cell Science, 2012; 125: 5591–5596.
Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, Gong Z, Zhang S, Zhou J, Cao K, Li X, Xiong W, Li G, Zeng Z, Guo C. Role of Tumor Microenvironment in Tumorigenesis. Journal of Cancer, 2017; 8(5): 761– 773.
Hanchen L, Xueli F, Houghton J. Tumor Micrenvironment: The Role of the Tumor Stroma in Cancer. Journal of Cellular Biochemistry, 2007; 101: 805–815.
Stewart C. Stem Cell Origin of Cancer and Differentiation Therapy. Critical Reviews in Oncology/Hematology, (2004); 51: 1–28.
Li F, Tiede B, Massagué J, Kang Y. Beyond Tumorigenesis: Cancer Stem Cells in Metastasis. Cell Research, 2007; 17: 3–14.
Egeblad M, Nakasone ES, Werb Z. Tumors as Organs: Complex Tissues that Interface with the Entire Organism. Dev Cell, 2010; 18(6): 884–901.
Shiozawa Y, Nie B, Pienta KJ, Morgan TM, Taichman RS. Cancer Stem Cells and their Role in Metastasis. Pharmacol Ther, (2013; 138(2): 285–293.
Chang JC. Cancer Stem Cells: Role of Tumor Growth, Recurrence, Metastasis and Treatment Resistance. Medicine, 2016; 95: S1.
Medema JP. Cancer Stem Cells: The Challenges Ahead. Nature Cell Biology, 2013; 15(4): 338–344.
Krebs HA, Otto Heinrich Warburg, Biographical Memoirs, 1883–1970.
Warburg O. On the Origin of Cancer Cells. Science, (1956); 123(3191): 309–314.
Hsu PP, Sabatini DM. Cancer Cell Metabolism: Warburg and Beyond. Cell, 2008; 134: 703–707.
Hanselmann RG, Welter C. Origin of Cancer: An information, Energy, and Matter Disease. Frontiers in Cell and Development Biology, 2016; 4: 121.
Epstein T, Gatenby RA, Brown JS. The Warburg Effect as an Adaptation of Cancer Cells to Rapid Fluctuations in Energy Demand. PLoS ONE, 2017; 12(9).
Fernandez-de-Cossio-Diaz J, Vasquez A. Limits of Aerobic Metabolism in Cancer Cells. Scientific Report, (2017); 7: 13488.
Romero-Garcia S, Lopez-Gonzalez JS, Báez-Viveros JL, Aguilar- Cazares D, Prado-Garcia H. Tumor cell Metabolism: An integral view. Cancer Biology and Therapy, (2011); 12(11): 939–948.
López-Lázar M. The Warburg Effect: Why and How do Cancer Cells Activate Glycolysis in the Presence of Oxygen? Anti-Cancer Agents in Medical Chemistry, 2008; 8: 305–312.
Devic S. Warburg Effect–a Consequence or the Cause of Carcinogenesis? Journal of Cancer, 2016; 7(7): 817–822.
Kim S. Cancer Energy Metabolism: Shutting Power off Cancer Factory. Biomolecules and Therapeutics, 2018; 26(1): 39–44.
Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. The Reverse Warburg Effect: Aerobic Glycolysis in Cancer Associated
Fibroblasts and the Tumor Stroma. Cell Cycle 2009; 8(23): 3984–4001.
Fu Y, Liu S, Yin S, Niu W, Xiong W, Tan M, Li G, Zhou M. The Reverse Warburg Effect is Likely to be and Achilles´s Heels of Cancer that Can be Exploited for Cancer Therapy. Oncotarget, (2017); 8(34): 57813– 57825.
Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends–An Update. Cancer Epidemiology, Biomarkers and Preventions, DOI: 10.1158/1055–9965.EPI-15–0578
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. A Cancer Journal for Clinicians, 2018; 68: 394–424.
Prostate Cancer UK. Prostate Cancer: A Guide for Men Who have just Been Diagnosed, 2016; 1–60.
The Prostate Cancer Foundation. Patient Guide, Prostate Cancer: A Comprehensive Resource on Diagnosis Treatment, Side Effects, and Risk Factors for Patients and Families with a History of Prostate Cancer, 2017; 1–72.
Hammerich KH, Ayala GE, Wheeler TM. Anatomy of the Prostate Gland and Surgical Pathology of Prostate Cancer. Hricak H, Scardino PT, Prostate Cancer, UK, Cambridge University Press, 2009; 1–14.
Fine SW, Reuter VE. Anatomy of the Prostate Revisited: Implications for Prostate Biopsy and Zonal Origins of Prostate Cancer. Histopathology, 2012; 60: 142–152.
McNeal JE. The Zonal Anatomy of the Prostate. The Prostate (1981); 2: 35–49.
Eidelman E, Twum-Ampofo J, Ansari J, Siddiqui MM. The Metabolic Phenotype of Prostate Cancer. Frontiers in Oncology, 2017; 7: 131.
Cutruzzolá F, Giardina G, Marani M, Macone A, Paiardini A, Rinaldo S, Paone A. Glucose Metabolism in the Progression of Prostate Cancer. Frontiers in Physiology. 2017; 8: 97.
Dörr M, Schlesinger-Raab A, Engel J (2013). Epidemiology of Prostate Cancer, Advances in Prostate Cancer, Gerhard Hamilton, Intech Open, DOI: 10.5772/52150. Available from: https://www.intechopen.com/books/ad vances-in-prostate-cancer/epidemiolo gy-of-prostate-cancer
Banerjee S, Kaviani A. Worldwide Prostate Cancer Epidemilogy: Differences Between Regins, Races and Awareness Programs. International Journal, 2016; 2(1):1–6.
Adeloye D, David RA, Aderemi AV, Iseolorunkanmy A, Oyedokun A, Iweala EEJ, Omoregbe N, Ayo CK. An Estimate of the Incidence of Prostate Cancer in Africa: Systematic Review and Meta-Analysis. PLoS NE, 2016; 11(4): e0153496.
Hass GP, Delongchamps N, Brawley OW, Wang CY, de la Rosa G. The Worldwide Epidemiology of Prostate Cancer: Perspectives from Autopsy Studies. Can J Urol, 2008; 15(1): 3866–3871.
Brawley OW. Trends in Prostate Cancer in the United States. Journal of the National Cancer Institute Monographs, 2012; 45: 152–156.
Litwin MS, Tan H. The Diagnosis and Treatment of Prostate Cancer. Clinical Review and Education, 2017; 317(24): 2532–2542.
Pomerantz MM, Osman NY, Oh WK. Diagnosis and Treatment of Localized Prostate Cancer. Hospital Physician, 2008; 9–20.
Logothetis CJ, Gallick GE, Maity SN, Kim J, Aparicio A, Efstathiou E, Lin S. Molecular Classification of Prostate Cancer Progession: Foundation for Marker-Driven Treatment of Prostate Cancer. Cancer Discovery, 2013; 849–862.
Kumar RJ, Barqawi AB, Crawford ED. Epidemiology of Prostate Cancer. Business Briefing: US Oncology Review, 2004; 1–6.
Crawford ED. Epidemiology of Prostate Cancer. Urology 2003; 62: 1–10.
Sadeghi-Gandomani HR, Yousefi MS, Rahimi S, Yousefi SM, Karimi- Rozveh A, Hosseini S, Mahabadi AA, Abargui HF, Borujeni NN, Salehiniya H. The Incidence, Risk Factors and Knowledge about the Prostate Cancer through Worldwide and Iran. World Cancer Research Journal, 2017; 4(4): e972.
Bashir MN. Epidemiology of Prostate Cancer. Asian Pacific Journal of Cancer Prevention, 2015; 16: 5137– 5141.
Stark T, Livas L, Kyprianou N. Inflammation in Prostate Cancer Progression and Therapeutic Targeting. Translational Andrology and Urology, 2014; 4(4): 455–463.
Burton AJ, Tilling KM, Holly JM, Hamdy FC, Rowlands ME, Donovan JL, Martin RM. Metabolic Imbalance and Prostate Cancer Progression. Int J Mol Epidemiol Genet, 2010; 1(4): 248–271.
Han I-H, Kim J-H, Jang K-S, Ryu J-
S. Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells. The Prostate, 2019; 1–14.
Colmenter L, Troconis JE, Cornejo F, Adriana NJ, Ramos O, Lupera H.
Metabolism of the Prostate and Progression to Prostate Cancer.
Goldstein AS, Witte ON. Does the Microenvironment Influence the Cell Types of Origin for Prostate Cancer? Genes and Development, (2013); 27: 1539–1544.
McGarty TP. Warburg, Prostate Cancer. White Paper 2018; 149: 1– 14.
Toren P, Venkateswaran V. Periprostatic Adipose Tissue and Prostate Cancer Progession: New Insights into the Tumor Microenvironment. Clinical Geniturinary Cancer, 2014; 12(1): 21–26.
Cao Y, Givannucci E. Obesity and Prostate Cancer. Recent Results in Cancer Research, (2016); 208: 137– 153.
Allott EH, Masko EM, Freedland SJ. Obesity and Prostate Cancer: Weighing the Evidence. Eur Urol, 63(5): 800–809.
Freedland SJ, Aronson WJ. Examining the Relationship between Obesity and Prostate Cancer. Reviews in Urology, 2004; 6(2): 73– 81.
Fujita K, Hayashi T, Matsushita M, Uemura M and Nonomura N. Obesity, Inflammation and Prostate Cancer. Journal of Clinical Medicine, 2019; 8: 201.
Strand DW, Goldstein AS. The Many Ways to Make a Luminal Cell and a Prostate Cancer Cell. Endocrine- Related Cancer, 2015; 22: 187–197.
Garber K. A Tale of Two Cells: Discovering the Origin of Prostate Cancer. Journal of the National Cancer Institute, (2010); 102(20): 1528–1530.
Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a Cell of Origin for
Human Prostate Cancer. Science, 2010; 329: 568–571.
Wang ZA, Toivanen R, Bergren Sk, Chambon P, Shen MM. Luminal Cells Are Favored as the Cell of Origin for Prostate Cancer. Cell Reports, 2014; 8: 1339–1346.
Kwon O, Zhang L, Ittmann MM, Xin
L. Prostatic Inflammation Enhances Basal-to-Luminal Differentiation and Accelerates Initiation of Prostate Cancer with a Basal Cell Origin. Proceedings of the National Academy of Sciences, 2013; 592– 600.
Zhang D, Zhao S, Li X, Kirk JS, Tang DG. Prostate Luminal Progenitor Cells in Development and Cancer. Trends in cancer, 2018; 300: 1–15.
Adult Fitness Concepts. Private Gym: Pelvic Muscle Exercise System for Men. 2012.
Dorey G, Siegel A, Nelson P. The Effect of a Pelvic Floor Muscle Training Program Using Active and
Resisted Exercises on male Sexual Function: A Randomized Controlled Trial, 1–15.
Lee J, Bae S, Jeong J, Kim S, Kim K. Hypoxia-inducible Factor (HIF-1) α: Its Protein Stability and Biological Functions. Experimental and Molecular Medicine, 2004; 36(1): 1– 12.
The Ohio State University Comprehensive Cancer Center. Patient Education: Kegel or Pelvic Floor Muscle Exercises for Men, (2017); 1– 3.
LaBrecque BM. Kegels: Male Pelvic Floor Exercises. University of Michigan Health System, (2009); 1– 2.
National Continence Helpline. Pelvic Floor Muscle Training for Men, 2010; 1–4.
Hofmann P. Cancer and Exercise: Warburg Hypothesis, Tumor Metabolism and High–Intensity Anaerobic Exercise. Sports, 2017; 6(10): 1–24
DOI: https://doi.org/10.37628/ijcbcp.v5i2.498
Refbacks
- There are currently no refbacks.